Bharat Biotech’s Covaxin enters for Phase-3 Trials in AIIMS Hospital
The phase-three human clinical test of Covaxin against the novel coronavirus started at the AIIMS in New Delhi. Bharat Biotech ...
Tag: Covid-19
‘Atma Nirbhar Bharat’ in disposable syringes
AISNMA addressed a letter to the Prime Minister of India. AISNMA is reportedly the single nodal organisation for syringe manufacturers ...
SC condemns Gujarat and asks Delhi to toughen the belt
The Supreme Court asked all states to submit action plans in two days to ensure the pandemic does not surge. ...
Union Minister Piyush Goyal emphasises on the need for a united self-reliant India to fight Covid
At the Asia Health 2020 session, Union Minister Goyal highlighted GOI's Atmanirbhar Bharat initiative. He focused on India's role as ...
GOI to acquire Oxford vaccine shots by Jan-Feb
India will soon have two-shot doses of Oxford's AstraZeneca by Jan-Feb 2021 The vaccine will be procured at half the ...
40 million COVID-19 vaccines to be prepared by year-end: White House
Trump administration is set with a scheme to distribute COVID-19 vaccine across the country. The year-end will prepare forty million ...
Eli Lilly’s Olumniant (barcitinab) receives EUA from the US FDA for COVID-19 treatment
USFDA published an Emergency Use Authorisation (EUA) for the drug Baricitinib. Remdesivir is an FDA-approved intravenous antiviral drug for use ...
Pfizer submitted data on COVID vaccine large-scale phase 3 trial to EU drug Regulator
Leaders from AAP, BJP, and Congress were invited to put forward their points. The alarming rise in Covid cases indicates ...
‘Outsiders’ increasing the COVID-19 cases in the Capital- Delhi Minister
Aggressive testing of people, 25-30% of whom were not residents of the capital. Most patients from other states arrive here ...
Samsung BioLogics mass-producing Eli Lilly’s COVID-19 remedy
Samsung BioLogics Co Ltd stated it is mass-producing a COVID-19 antibody medication. The FDA affirmed the drug 'bamlanivimab' after clinical ...
